Enhancement of the International prognostic index with β2-microglobulin, platelet count and red blood cell distribution width: a new prognostic model for diffuse large B-cell lymphoma in the rituximab era.
Haizhu ChenQiaofeng ZhongYu ZhouYan QinJianliang YangPeng LiuXiaohui HeShengyu ZhouChanggong ZhangLin GuiSheng YangLiqiang ZhouYuan-Kai ShiPublished in: BMC cancer (2022)
The new prognostic model might be a useful predictive tool for DLBCL treated with R-CHOP regimens. Further external validation is warranted.